Previous Page  4 / 25 Next Page
Information
Show Menu
Previous Page 4 / 25 Next Page
Page Background

Page 68

Notes:

conferenceseries

.com

Volume 8

Journal of Gastrointestinal & Digestive System

ISSN: 2161-069X

Bariatric Surgery 2018 & Gastro 2018

March 15-16, 2018

JOINT EVENT

12

th

Global Gastroenterologists Meeting

3

rd

International Conference on Metabolic and Bariatric Surgery

&

March 15-16, 2018 Barcelona, Spain

Epidemiological and clinical evaluation of hepatitis b, hepatitis c, and delta viruses in Tajikistan

Khakimova Zebinniso

Institute of Gastroenterology - Academy of Medical Sciences of the Ministry of Health and Social Protection, Tajikistan

T

he implication of genotypes is recognized increasingly in the clinical course of hepatitis B virus (HBV) and in response

to anti-viral drugs of hepatitis C virus (HCV). Genotypic prevalence of both etiological agents variesgeographicallyand

no data are available for Tajikistan. To investigate the epidemiology and clinical significance of HBV and HCVgenotypes in

chronic hepatitis (group 1) and liver cirrhosis/hepatocellular carcinoma (HCC) (group2) patients in Tajikistan, 124 patients

with chronic liver disease (group 1=84 and group 2=40) were enrolled. Genotypes of HBV, HCV, and delta hepatitis virus

(HDV) were deter¬mined by sequencing. The overall prevalence of anti-HCV, HCV coreantigen (HCVcAg)and HBsAg was

46% (57/124) and 41.1% (51/124), respec¬tively. Coinfection of HCV/HBV, HBV/HDV, and HCV/HBV/HDV was found in

4.8% (6/124), 11.2% (12/124), and 0.8% (1/124) of cases, respectively. HDV genotype 1 was found in 19.6% (10/51) of HBsAg-

positive patients. The HBV/HDV coinfec- tion was relatively high in group 2 compared to group 1 (15%vs.7.1%). HCV/1b

detected in 84.6% (44/52) of HCVRNA-positive patients,followed by 3a (7.6%), 2a (5.7%), and 2c (1.9%). HBV/D was detected

in 94.1% (48/51) of HBsAg-positive patients, followed by HBV/A [5.8% (3/51)]. T1762/A1764 double mutation was associated

with livercirrhosis/HCC in HBV-infected patients (P=0.0004). This is the first study on the molecular epidemiology of hepatitis

viruses among chronic liver diseases patients in Tajikistan. Among HBV-infected patients, the T1762/A1764 mutation was

associated with liver cirrhosis/HCC.

Biography

Khakimova Zebinniso is affiliated to the Department of Virology, Institute of Gastroenterology of the Republic of Tajikistan. She has published more than 5 papers

in reputed journals.

dustovsamad@gmail.com

Khakimova Zebinniso, J Gastrointest Dig Syst 2018, Volume 8

DOI: 10.4172/2161-069X-C1-065